203 related articles for article (PubMed ID: 33973356)
1. Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress.
Jiang ZB; Gao J; Chai YH; Li W; Luo YF; Chen YZ
Kaohsiung J Med Sci; 2021 Aug; 37(8):718-729. PubMed ID: 33973356
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of E Se tea extracts against alcoholic fatty liver disease induced by high fat/alcohol diet: In vivo biological evaluation and molecular docking study.
Wang Y; Fan Z; Yang M; Wang Y; Cao J; Khan A; Liu Y; Cheng G
Phytomedicine; 2022 Jul; 101():154113. PubMed ID: 35490493
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease.
Liang XY; Hong FF; Yang SL
Diabetes Metab Syndr Obes; 2021; 14():1871-1883. PubMed ID: 33953586
[TBL] [Abstract][Full Text] [Related]
4. Aqueous Extract of Pepino (
Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
[TBL] [Abstract][Full Text] [Related]
5. The Role of Oxidative Stress in Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Preclinical Studies.
Rabelo ACS; Andrade AKL; Costa DC
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674865
[TBL] [Abstract][Full Text] [Related]
6. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
[TBL] [Abstract][Full Text] [Related]
7. [Protective effect of astragaloside IV on oxidative damages of chang liver cell induced by ethanol and H2O2].
Han L; Li J; Lin X; Ma YF; Huang YF
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4430-5. PubMed ID: 25850280
[TBL] [Abstract][Full Text] [Related]
8. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance.
Kong L; Chen J; Ji X; Qin Q; Yang H; Liu D; Li D; Sun M
J Exp Clin Cancer Res; 2021 Jan; 40(1):18. PubMed ID: 33413501
[TBL] [Abstract][Full Text] [Related]
9. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways.
Wei Z; Xue Y; Xue Y; Cheng J; Lv G; Chu L; Ma Z; Guan S
J Pharmacol Sci; 2021 Sep; 147(1):72-80. PubMed ID: 34294375
[TBL] [Abstract][Full Text] [Related]
10. Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function.
Luo Y; Wan Q; Xu M; Zhou Q; Chen X; Yin D; He H; He M
Chem Biol Interact; 2019 Aug; 309():108723. PubMed ID: 31228469
[TBL] [Abstract][Full Text] [Related]
11. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe
Hua YQ; Zeng Y; Xu J; Xu XL
Phytomedicine; 2021 Jan; 81():153412. PubMed ID: 33234364
[TBL] [Abstract][Full Text] [Related]
12. Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway.
Xiao J; Wang J; Xing F; Han T; Jiao R; Liong EC; Fung ML; So KF; Tipoe GL
PLoS One; 2014; 9(4):e95214. PubMed ID: 24740309
[TBL] [Abstract][Full Text] [Related]
13. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression.
Su Y; Chen Q; Ma K; Ju Y; Ji T; Wang Z; Li W; Li W
Pharmacol Rep; 2019 Apr; 71(2):319-329. PubMed ID: 30826573
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production.
Ma Z; Zhang Y; Li Q; Xu M; Bai J; Wu S
PLoS One; 2017; 12(8):e0183426. PubMed ID: 28817659
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF-
Xu L; Yu Y; Sang R; Li J; Ge B; Zhang X
Oxid Med Cell Longev; 2018; 2018():8284107. PubMed ID: 30344887
[TBL] [Abstract][Full Text] [Related]
17. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
Guan FY; Yang SJ; Liu J; Yang SR
Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV Alleviates Ammonia-Induced Apoptosis and Oxidative Stress in Bovine Mammary Epithelial Cells.
Wang F; Zhao Y; Chen S; Chen L; Sun L; Cao M; Li C; Zhou X
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704086
[TBL] [Abstract][Full Text] [Related]
19. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway.
Xu Z; Liu W; Huang H
Pharmacology; 2020; 105(3-4):181-189. PubMed ID: 31825924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
